A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure. (Q51472824)
Jump to navigation
Jump to search
scientific article published on 6 April 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure. |
scientific article published on 6 April 2007 |
Statements
1 reference
A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure. (English)
1 reference
1 reference
John J V McMurray
1 reference
Henry J Dargie
1 reference
Per R Hildebrandt
1 reference
Günter A J Riegger
1 reference
Stephen O McMorn
1 reference
Jeremy N Roberts
1 reference
Andrew Zambanini
1 reference
6 April 2007
1 reference
49
1 reference
1696-1704
1 reference
16
1 reference
Identifiers
1 reference